TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

NCT05729711 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)

Sponsor

AstraZeneca